Alaunos Therapeutics Inc (TCRT)
2.32
-0.08
(-3.33%)
USD |
NASDAQ |
Nov 14, 16:00
2.32
0.00 (0.00%)
After-Hours: 20:00
Alaunos Therapeutics Free Cash Flow (Quarterly): -1.681M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.681M |
| March 31, 2024 | -1.917M |
| December 31, 2023 | -7.385M |
| September 30, 2023 | -6.375M |
| June 30, 2023 | -7.137M |
| March 31, 2023 | -9.442M |
| December 31, 2022 | -7.246M |
| September 30, 2022 | -6.159M |
| June 30, 2022 | -8.244M |
| March 31, 2022 | -7.799M |
| December 31, 2021 | -15.48M |
| September 30, 2021 | -9.947M |
| June 30, 2021 | -23.33M |
| March 31, 2021 | -16.03M |
| December 31, 2020 | -20.80M |
| September 30, 2020 | -18.08M |
| June 30, 2020 | -17.49M |
| March 31, 2020 | -10.42M |
| December 31, 2019 | -11.71M |
| September 30, 2019 | -11.03M |
| June 30, 2019 | -8.154M |
| March 31, 2019 | -10.24M |
| December 31, 2018 | -11.73M |
| September 30, 2018 | -8.676M |
| June 30, 2018 | -10.40M |
| Date | Value |
|---|---|
| March 31, 2018 | -19.11M |
| December 31, 2017 | -12.43M |
| September 30, 2017 | -12.79M |
| June 30, 2017 | -15.55M |
| March 31, 2017 | -14.64M |
| December 31, 2016 | -13.15M |
| September 30, 2016 | -14.32M |
| June 30, 2016 | -15.17M |
| March 31, 2016 | -16.24M |
| December 31, 2015 | -24.19M |
| September 30, 2015 | 45.20M |
| June 30, 2015 | -11.70M |
| March 31, 2015 | -9.734M |
| December 31, 2014 | -9.87M |
| September 30, 2014 | -10.58M |
| June 30, 2014 | -7.732M |
| March 31, 2014 | -8.656M |
| December 31, 2013 | -9.058M |
| September 30, 2013 | -15.50M |
| June 30, 2013 | -16.72M |
| March 31, 2013 | -18.36M |
| December 31, 2012 | -21.58M |
| September 30, 2012 | -15.08M |
| June 30, 2012 | -17.72M |
| March 31, 2012 | -26.01M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-23.33M
Minimum
Jun 2021
-1.681M
Maximum
Jun 2024
-10.88M
Average
-9.442M
Median
Mar 2023
Free Cash Flow (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -9.917M |
| Oragenics Inc | -1.544M |
| Cocrystal Pharma Inc | -3.699M |
| Cara Therapeutics Inc | -12.65M |
| Jaguar Health Inc | -8.186M |